COMPOUND PROFILE / PEPTIDES & ANALOGUES
MOTS-c.
Research draftMOTS-c is a mitochondrial-derived peptide studied in metabolic and stress-response biology.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
MOTS-c is a mitochondrial-derived peptide studied in metabolic and stress-response biology.
Mechanism
Experimental studies implicate AMPK-related metabolic signalling and cellular adaptation.
Human research
Human measurements of endogenous MOTS-c do not show that injected MOTS-c is effective. Native peptide and modified analogues require separate assessment.
Preclinical & other research
Animal and cell experiments report metabolic and inflammatory effects.
Safety & unknowns
Therapeutic human exposure, long-term effects and injectable-product safety remain insufficiently characterised.
Regulatory status
An endogenous molecule is not automatically an approved medicine.
Reported use & evidence
The supplied MOTS-c profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.